Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”

• Still Daniel PharmD, BCPP,
• Do Kathy PharmD,
• Thompson Paul PharmD, BCPP,
• Brackins Todd PharmD, BCPP,
• McGrory James PhD

Affiliations

Still Daniel PharmD, BCPP

ORCiD

1 Senior Director, Medical Science, Medical Affairs, Alkermes Inc, Waltham, Massachusetts

Do Kathy PharmD

ORCiD

2 Associate Director, Medical Information, Alkermes Inc, Waltham, Massachusetts

Thompson Paul PharmD, BCPP

ORCiD

3 Senior Medical Science Liaison, Alkermes Inc, Waltham, Massachusetts

Brackins Todd PharmD, BCPP

ORCiD

4 Director, Scientific Training and Development, Medical Affairs, Alkermes Inc, Waltham, Massachusetts

McGrory James PhD

ORCiD

5 Medical Director and Product Lead, Alkermes Inc, Waltham, Massachusetts